These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9211201)

  • 1. The natural history of vascular disease in homocystinuria and the effects of treatment.
    Wilcken DE; Wilcken B
    J Inherit Metab Dis; 1997 Jun; 20(2):295-300. PubMed ID: 9211201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B vitamins and homocysteine in cardiovascular disease and aging.
    Wilcken DE; Wilcken B
    Ann N Y Acad Sci; 1998 Nov; 854():361-70. PubMed ID: 9928444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.
    Wilcken DE; Dudman NP; Tyrrell PA
    Metabolism; 1985 Dec; 34(12):1115-21. PubMed ID: 3934499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.
    Yap S; Boers GH; Wilcken B; Wilcken DE; Brenton DP; Lee PJ; Walter JH; Howard PM; Naughten ER
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2080-5. PubMed ID: 11742888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor pathway inhibitor levels in patients with homocystinuria.
    Cella G; Burlina A; Sbarai A; Motta G; Girolami A; Berrettini M; Strauss W
    Thromb Res; 2000 Jun; 98(5):375-81. PubMed ID: 10828477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine.
    Wilcken DE; Wilcken B; Dudman NP; Tyrrell PA
    N Engl J Med; 1983 Aug; 309(8):448-53. PubMed ID: 6877313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine beta-synthase deficiency.
    Yap S; Rushe H; Howard PM; Naughten ER
    J Inherit Metab Dis; 2001 Aug; 24(4):437-47. PubMed ID: 11596648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control.
    Yap S; Naughten E
    J Inherit Metab Dis; 1998 Oct; 21(7):738-47. PubMed ID: 9819703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years.
    Walter JH; Wraith JE; White FJ; Bridge C; Till J
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S71-6. PubMed ID: 9587030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical homocystinuria: vascular risk and its prevention.
    Yap S
    J Inherit Metab Dis; 2003; 26(2-3):259-65. PubMed ID: 12889665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of homocystinuria due to cystathionine beta-synthase deficiency.
    Mudd SH; Skovby F; Levy HL; Pettigrew KD; Wilcken B; Pyeritz RE; Andria G; Boers GH; Bromberg IL; Cerone R
    Am J Hum Genet; 1985 Jan; 37(1):1-31. PubMed ID: 3872065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.
    Kluijtmans LA; Boers GH; Kraus JP; van den Heuvel LP; Cruysberg JR; Trijbels FJ; Blom HJ
    Am J Hum Genet; 1999 Jul; 65(1):59-67. PubMed ID: 10364517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency.
    Reish O; Townsend D; Berry SA; Tsai MY; King RA
    Am J Hum Genet; 1995 Jul; 57(1):127-32. PubMed ID: 7611281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-bound homocyst(e)ine in normal subjects and in patients with homocystinuria.
    Kang SS; Wong PW; Becker N
    Pediatr Res; 1979 Oct; 13(10):1141-3. PubMed ID: 503641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive fitness in maternal homocystinuria due to cystathionine beta-synthase deficiency.
    Levy HL; Vargas JE; Waisbren SE; Kurczynski TW; Roeder ER; Schwartz RS; Rosengren S; Prasad C; Greenberg CR; Gilfix BM; MacGregor D; Shih VE; Bao L; Kraus JP
    J Inherit Metab Dis; 2002 Aug; 25(4):299-314. PubMed ID: 12227460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine transamination in patients with homocystinuria due to cystathionine beta-synthase deficiency.
    Tangerman A; Wilcken B; Levy HL; Boers GH; Mudd SH
    Metabolism; 2000 Aug; 49(8):1071-7. PubMed ID: 10954028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria.
    Singh RH; Kruger WD; Wang L; Pasquali M; Elsas LJ
    Genet Med; 2004; 6(2):90-5. PubMed ID: 15017331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystathionine β-synthase deficiency in the E-HOD registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis.
    Kožich V; Sokolová J; Morris AAM; Pavlíková M; Gleich F; Kölker S; Krijt J; Dionisi-Vici C; Baumgartner MR; Blom HJ; Huemer M;
    J Inherit Metab Dis; 2021 May; 44(3):677-692. PubMed ID: 33295057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
    Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
    Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.